Eli Lilly LLY
NYSE LLY
$1,306.89 +36.14 (+2.84%)
As of: Oct 22, 2026 · 3:59 PM EDT

Eli Lilly (LLY) Depreciation & Amortization (CF) (2009 - 2026)

Updated

Eli Lilly (LLY) posted Depreciation & Amortization (CF) of $534 million for Q2 2026, up 11.7% from $478 million a year earlier and up 4.9% from the prior quarter.

Analysis

Eli Lilly (LLY) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Eli Lilly was $2.1 billion, up 10.9% year-over-year; for FY2025, it came in at $2 billion, up 13.0% from FY2024.

  • Annual Depreciation & Amortization (CF) has increased for three consecutive years, with a five-year compound annual growth rate of 8.6% (FY2020 to FY2025).
  • In prior years, Eli Lilly's Depreciation & Amortization (CF) was $1.77 billion in FY2024 (+15.7%), $1.53 billion in FY2023 (+0.3%), $1.52 billion in FY2022 (-1.6%) and $1.55 billion in FY2021 (+16.9%).
  • Quarterly Depreciation & Amortization (CF) has run from a low of $348.9 million in Q2 2022 to a high of $585.7 million in Q4 2025 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has increased in each of the last 13 quarters, with growth averaging 14.1% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q4 2024, with growth of 25.2%; the weakest was Q1 2023, with a decline of 16.8%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $509 million (Q1 2026), $585.7 million (Q4 2025) and $470.3 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 2.12 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 194.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 1.93 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 98.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 1.62 Bn
10 Vertex Pharmaceuticals 135.25 Bn 107.26 Bn 2.84 Bn 56.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 534.00 Mn
Mar 31, 2026 509.00 Mn
Dec 31, 2025 585.70 Mn
Sep 30, 2025 470.30 Mn
Jun 30, 2025 478.00 Mn
Mar 31, 2025 463.00 Mn
Dec 31, 2024 485.20 Mn
Sep 30, 2024 466.80 Mn
Jun 30, 2024 414.40 Mn
Mar 31, 2024 400.60 Mn
Dec 31, 2023 387.40 Mn
Sep 30, 2023 411.00 Mn
Jun 30, 2023 366.30 Mn
Mar 31, 2023 362.30 Mn
Dec 31, 2022 375.00 Mn
Sep 30, 2022 362.90 Mn
Jun 30, 2022 348.90 Mn
Mar 31, 2022 435.70 Mn
Dec 31, 2021 445.70 Mn
Sep 30, 2021 382.30 Mn
API Access

Eli Lilly Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=LLY&period=max&api_key=YOUR_API_KEY